GL1X · GenesisL1 explorer

MolNFT v1 · #76663 · protein

HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor

3QRO: “HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor”. X-ray diffraction, 2 ligands (NK9, CL), 1 pocket (best druggability 0.74). MolNFT v1 #76663 on GenesisL1: 3D structure, binding sites…

PDB
3QRO
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03367
Ligands
NK9, CL
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 56% strandP03367

Ligands and binding sites

  • NK9 · 4-({(3S,4S)-4-[(3,5-dihydroxybenzyl)amino]pyrrolidin-3-yl}[4-(trifluoromethyl)benzyl]sulfamoyl)benzamide · ligand · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B
  • DTD · Dithiane diol · additive · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.740.8433NK9, DTD

Interfaces

1 interface between chains.

  • A–B · 1853 Ų buried · 39 hydrogen bonds · protein-protein

Compared structures

  • 3QRO · HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.